Abstract:Background: Histone modification H4K20me3 and its methyltransferase SUV420H2 have been implicated in suppression of tumorigenesis. The underlying mechanism is unclear, although H4K20me3 abundance increases during cellular senescence, a stable proliferation arrest and tumor suppressor process, triggered by diverse molecular cues, including activated oncogenes. Here, we investigate the function of H4K20me3 in senescence and tumor suppression.Results: Using immunofluorescence and ChIP-seq we determine the distribution of H4K20me3 in proliferating and senescent human cells. Altered H4K20me3 in senescence is coupled to H4K16ac and DNA methylation changes in senescence. In senescent cells, H4K20me3 is especially enriched at DNA sequences contained within specialized domains of senescence-associated heterochromatin foci (SAHF), as well as specific families of non-genic and genic repeats. Altered H4K20me3 does not correlate strongly with changes in gene expression between proliferating and senescent cells; however, in senescent cells, but not proliferating cells, H4K20me3 enrichment at gene bodies correlates inversely with gene expression, reflecting de novo accumulation of H4K20me3 at repressed genes in senescent cells, including at genes also repressed in proliferating cells. Although elevated SUV420H2 upregulates H4K20me3, this does not accelerate senescence of primary human cells. However, elevated SUV420H2/H4K20me3 reinforces oncogene-induced senescence-associated proliferation arrest and slows tumorigenesis in vivo.Conclusions: These results corroborate a role for chromatin in underpinning the senescence phenotype but do not support a major role for H4K20me3 in initiation of senescence. Rather, we speculate that H4K20me3 plays a role in heterochromatinization and stabilization of the epigenome and genome of pre-malignant, oncogene-expressing senescent cells, thereby suppressing epigenetic and genetic instability and contributing to long-term senescence-mediated tumor suppression.

Selective pericentromeric heterochromatin dismantling caused by TP53 activation during senescence

The loss of heterochromatin is associated with multiscale three-dimensional genome reorganization and aberrant transcription during cellular senescence

Linked regulation of genome integrity and senescence-associated inflammation by p53

A mitochondria-regulated p53-CCF circuit integrates genome integrity with inflammation

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression

Centromere inactivation during aging can be rescued in human cells

Lysosome-mediated Processing of Chromatin in Senescence

Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Senescence-associated transcriptional derepression in subtelomeres is determined in a chromosome-end-specific manner.

Heterochromatin formation and remodeling by IRTKS condensates counteract cellular senescence

Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging

Mapping H4K20me3 Onto the Chromatin Landscape of Senescent Cells Indicates a Function in Control of Cell Senescence and Tumor Suppression Through Preservation of Genetic and Epigenetic Stability

Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice

Independence of Repressive Histone Marks and Chromatin Compaction During Senescent Heterochromatic Layer Formation

Effects of p53 and ATRX inhibition on telomeric recombination in aging fibroblasts

A Switch-Like Dynamic Mechanism for the Initiation of Replicative Senescence

Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

Dynamics of Telomeric Chromatin at the Crossroads of Aging and Cancer

Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening